Clinical Trial Update: A Study of DXC014 in Patients With Advanced Solid Tumors. [Phase 1]

View source ↗

Summary

Phase 1 study of the investigational drug DXC014 in advanced solid tumors is currently recruiting. It includes patients with small cell lung cancer, melanoma, p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Prostate Cancer
• Small Cell Lung Cancer

Drugs mentioned

• DXC014

Snippet

Sponsor: Hangzhou DAC Biotechnology Co., Ltd. | Conditions: Small Cell Lung Cancer, Melanoma | Phase 1 | Status: RECRUITING